首页|Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
Glaucoma: Management and Future Perspectives for Nanotechnology-Based Treatment Modalities
扫码查看
点击上方二维码区域，可以放大扫码查看
原文链接
NSTL
Elsevier
Glaucoma, being asymptomatic for relatively late stage, is recognized as a worldwide cause of irreversible vision loss. The eye is an impervious organ that exhibits natural anatomical and physiological barriers which renders the design of an efficient ocular delivery system a formidable task and challenge scientists to find alternative formulation approaches. In the field of glaucoma treatment, smart delivery systems for targeting have aroused interest in the topical ocular delivery field owing to its potentiality to oppress many treatment challenges associated with many of glaucoma types. The current momentum of nano-pharmaceuticals, in the development of advanced drug delivery systems, hold promises for much improved therapies for glaucoma to reduce its impact on vision loss.
NSTL
Elsevier
